CGH
RMD icon

Crossmark Global Holdings’s ResMed RMD Stock Holding History

Crossmark Global Holdings’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48M Sell
7,620
-18,206
-70% -$3.77M 0.02% 535
2026
Q1 		$5.8M Sell
25,826
-1,816
-7% -$453K 0.09% 236
2025
Q4 		$6.66M Sell
27,642
-2,666
-9% -$682K 0.1% 217
2025
Q3 		$8.3M Buy
30,308
+17,487
+136% +$4.78M 0.12% 187
2025
Q2 		$3.31M Buy
12,821
+1,862
+17% +$444K 0.05% 319
2025
Q1 		$2.45M Buy
10,959
+4,116
+60% +$961K 0.04% 373
2024
Q4 		$1.56M Sell
6,843
-891
-12% -$215K 0.03% 458
2024
Q3 		$1.89M Sell
7,734
-499
-6% -$112K 0.03% 431
2024
Q2 		$1.58M Sell
8,233
-228
-3% -$46.3K 0.03% 460
2024
Q1 		$1.68M Sell
8,461
-84
-1% -$15.4K 0.03% 471
2023
Q4 		$1.47M Sell
8,545
-538
-6% -$82.7K 0.03% 485
2023
Q3 		$1.37M Sell
9,083
-1,114
-11% -$201K 0.03% 486
2023
Q2 		$2.27M Buy
10,197
+323
+3% +$72K 0.05% 377
2023
Q1 		$2.16M Sell
9,874
-391
-4% -$84.8K 0.05% 382
2022
Q4 		$2.14M Buy
10,265
+1,500
+17% +$330K 0.05% 377
2022
Q3 		$1.91M Sell
8,765
-63
-0.7% -$14.3K 0.05% 373
2022
Q2 		$1.85M Buy
8,828
+160
+2% +$34.1K 0.05% 402
2022
Q1 		$2.1M Buy
8,668
+350
+4% +$84.7K 0.05% 397
2021
Q4 		$2.17M Sell
8,318
-4,690
-36% -$1.22M 0.05% 384
2021
Q3 		$3.43M Sell
13,008
-650
-5% -$178K 0.08% 257
2021
Q2 		$3.37M Sell
13,658
-1,040
-7% -$219K 0.08% 258
2021
Q1 		$2.85M Sell
14,698
-1,130
-7% -$227K 0.07% 284
2020
Q4 		$3.36M Buy
15,828
+3,041
+24% +$606K 0.09% 262
2020
Q3 		$2.19M Sell
12,787
-1,054
-8% -$195K 0.06% 319
2020
Q2 		$2.66M Sell
13,841
-621
-4% -$102K 0.08% 273
2020
Q1 		$2.13M Sell
14,462
-80
-0.6% -$12.7K 0.08% 275
2019
Q4 		$2.25M Buy
14,542
+2,258
+18% +$325K 0.06% 333
2019
Q3 		$1.66M Sell
12,284
-93,605
-88% -$12.3M 0.05% 409
2019
Q2 		$12.9M Sell
105,889
-1,827
-2% -$202K 0.36% 59
2019
Q1 		$11.2M Buy
107,716
+332
+0.3% +$34.3K 0.32% 71
2018
Q4 		$12.2M Sell
107,384
-7,058
-6% -$756K 0.38% 57
2018
Q3 		$13.2M Buy
114,442
+3,142
+3% +$344K 0.34% 61
2018
Q2 		$11.5M Buy
111,300
+4,207
+4% +$426K 0.31% 69
2018
Q1 		$10.5M Sell
107,093
-789
-0.7% -$74.6K 0.27% 83
2017
Q4 		$9.14M Buy
107,882
+8,939
+9% +$738K 0.22% 113
2017
Q3 		$7.62M Buy
+98,943
New +$7.57M 0.2% 126
2016
Q3 		$7.62M Buy
+98,943
New +$6.59M 0.2% 126

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Crossmark Global Holdings's RMD Position: Q2 2026 in Review

Crossmark Global Holdings reduced its ResMed (RMD) stake by 70% in Q2 2026, selling an estimated $3.77M and leaving 7,620 shares worth $1.48M. The position accounts for 0.02% of the portfolio, ranked #535.

Crossmark Global Holdings first reported a position in RMD in Q3 2016 and has held it in 37 quarters since. The position peaked at $13.2M in Q3 2018. 135 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Crossmark Global Holdings held 7,620 shares of ResMed worth $1.48M as of Q2 2026.
  • Crossmark Global Holdings sold 18,206 ResMed shares in Q2 2026, an estimated $3.77M.
  • ResMed made up 0.02% of Crossmark Global Holdings's portfolio in Q2 2026, its #535 holding.
  • Crossmark Global Holdings first reported a position in ResMed in Q3 2016 and has held it in 37 quarters since.
  • Crossmark Global Holdings's ResMed position peaked at $13.2M in Q3 2018.
  • 135 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.